The Ministry of Health’s decision to halt unregulated parallel importation of medicines and health technologies marks an important step in strengthening Kenya’s pharmaceutical regulatory system.
More than a policy shift, it is a reaffirmation that improving access to medicines should never come at the expense of patient safety, quality or public confidence.
